Effectiveness of the implementation of clinical-epidemiological management during COVID-19 in a medium-long-stay hospital
e202007084
Keywords:
COVID-19, Spinal cord injury, Pandemic, Contingency plans, Internal Medicine, Coronavirus infections, Public healthAbstract
Background: The effects of the Covid-19 health emergency have demonstrated the high vulnerability of people residing in medium and long-stay centers, with high mortality rates. Little data is available about contingency protocols to minimize the spread of the virus in these centers. The goal of this study was to describe the clinical and epidemiological features of patients affected by SARS-CoV-2 and the preventive and management measures adopted at the National Hospital for Paraplegics (Toledo, Castilla-La Mancha, Spain) to minimize the risk of transmission of Covid-19.
Methods: A team of specialists in Preventive and Internal Medicine established a protocol for active surveillance, identification of suspected and confirmed cases, and follow-up of contacts. Also, a Unit for the care of confirmed cases was created with personnel specifically trained in Covid-19, to achieve better patient care and optimize the available resources. Descriptive statistical measures have been used to analyze the data.
Results: The prevalence of Covid-19 was 12.2%, with a cumulative incidence of 8.2%. After the protocol was established, control of the disease was achieved without hospital transmission after its application. Due to the alarm generated at the start of the pandemic, up to 45% of the requested RT-PCRs did not meet the criteria of the Ministry of Health, all of which were negative. The clinical characteristics of our patients differed slightly from those observed in other studies published in the general population, with cough and asthenia being the most frequent symptoms, present in 69.2% and 38.5%, respectively. 100% of the infected patients did not present complications that required assistance in the Intensive Care Unit.
Conclusions: With the application of preventive and organizational actions, we consider that we have presented a low incidence of those infected. The preparation of protocols and their supervision is essential for the rapid identification of cases and optimization of the tests requested. Despite being a medium and long-stay hospital, we have not presented any mortality or complications that required admission to the Intensive Care Unit.
Downloads
References
Guan WJ, Ni ZY, Hu Y et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-1720.
World Health Organization. Coronavirus disease 2019 (COVID-19): situation report. June, 30 2020. Disponible en: https://covid19.who.int.
Gallego Berciano P. Impacto de COVID-19 en los centros sociosanitarios. Rev Esp Salud Publica. Mayo 2020.
Comas-Herrera A, Zalakain J, Litwin C et al. Mortality associated with COVID-19 outbreaks in care homes: early international evidence. Article in LTCcovid.org, International LongTerm Care Policy Network, CPEC-LSE, 26 April 2020.
Rodríguez-Cola M, Jiménez-Velasco I, Gutiérrez-Henares F et al. Clinical features of coronavirus disease 2019 (COVID-19) in a cohort of patients with disability due to spinal cord injury. Spinal Cord Ser Cases 6, 39 (2020).
Righi G, Del Popolo G. COVID-19 tsunami: the first case of a spinal cord injury patient in Italy. Spinal Cord Ser Cases 6, 22 (2020).
Arevalo-Martin A, Grassner L, Garcia-Ovejero D et al. Elevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring Antibodies. Front Immunol. 2018;9:2365.
SCI and COVID-19 Respiratory Rehabilitation Protocol. Spain. [Internet] Disponible en: https://www.iscos.org.uk/uploads/CV-19/updated%20files%204%2024%2020/ENG _SCI_and_COVID_19_Respiratory.pdf.
Ministerio de Sanidad. Secretaría General de Sanidad y Consumo. Dirección General de Salud Pública, Calidad e Innovación. Centro de Coordinación de Alertas y Emergencias Sanitarias. Protocolo de actuación frente a casos de infección por el Nuevo coronavirus (SARS-CoV-2). Actualización el 31 de marzo de 2020. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCovChina/documentos/Procedimiento_COVID_19.pdf.
Carpio López D, Martínez Pillado M, Salgado Barreira A et al. Efectividad del plan de contingencia de la unidad de enfermedad inflamatoria intestinal ante la infección de COVID-19. Rev Esp Salud Publica. 2020; 94. 16 de junio e1-9.
Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK-ninth update. 23 April 2020. Stockholm: ECDC; 2020.
Emergenza COVID-19 nellestrutture socio assistenziali e sanitarie. [Internet] Disponible en: https://www.epicentro.iss.it/coronavirus/sars-cv-2-strutture-socio-assistenziali-sanitarie.
Klok FA, Kruip MJHA, van der Meer NJM et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147.
Kollias A, Kyriakoulis KG, Dimakakos E et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020;189(5):846-847.
Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054-62.
Lam P-P, Coleman BL, Green K et al. Predictors of influenza among older adults y the emergency department. BMC Infect Dis 2016; 16;615.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Antonio José Ruiz Moruno, Miguel Rodríguez Cola, Irena Jiménez Velasco, Rosa María Ruíz Delgado, Alicia González Rubio
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
